Aanika’s Science-Led Insurance Model Launches with $50M in Q2 Risk Transfer, Reshaping Agricultural Risk

Aanika is already on track to exceed $50 million in risk exposure by the end of the month — a milestone that signals the company’s transition from R&D to full commercial operations. That figure is expected to more than double over the next 12 months, fueled by growing demand from leading cooperatives and agribusinesses nationwide. This rollout underscores Aanika’s growing role as a new kind of agri-insurer — one that merges biotech, data science, and capital protection into a single, scalable ecosystem.

Marking the next step in its growth, Aanika will launch the Total Protection Network in Q2 2025—a first-of-its-kind risk platform built for the $4.6 trillion agriculture sector. As a Lloyd’s Coverholder, Aanika is integrating insurance, warranties, and mitigation tools to address the risks that traditional and weather-only products often overlook—serving farmers, co-ops, ag-retailers, and manufacturers across the value chain. Select products leverage Aanika’s proprietary traceability technology, now being deployed to tackle complex and underserved risks such as herbicide drift.

The network will fully integrate with Aanika’s B2B AI sales engine, trained on proprietary data, research, and internal analysis of agricultural trends. Built to scale distribution, the system delivers end-to-end risk management solutions and can generate the right Aanika product for each business—answering every question along the way.

“With the Total Protection Network, we’re introducing a fundamentally new infrastructure for risk in agriculture,” said Vishaal Bhuyan, CEO of Aanika Biosciences and Insurance Services. “This is a major leap forward in how agribusinesses can protect their capital and leverage cutting-edge technology to do so.”

Aanika was founded in 2018 by Vishaal Bhuyan, a former credit default swaps and insurance-linked derivatives trader, who now leads a team of experienced scientists and insurance underwriters. He is also the co-author of three books on insurance-linked securities, published by FT Press and John Wiley & Sons.

Aanika Biosciences was created to develop biological traceability technology using advanced molecular biology. It has since grown into a risk analytics platform, offering innovative insurance products for agribusinesses and applying scientific rigor to help businesses manage complex risks. The company has raised over $20 million to build its patented tech and insurance infrastructure, backed by Tim Draper / Draper Associates along with other industry leaders in agriculture and finance. Learn more at www.aanikabio.com or contact support@aanikabio.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250415867812/en/